How much funding has Aera Therapeutics raised?

Aera Therapeutics has raised $193.0M in total funding, most recently a Series A round.

Who are Aera Therapeutics's investors?

Aera Therapeutics's investors include ARCH Venture Partners, GV, Lux Capital, F-Prime Capital, Altitude Life Science Ventures.

When was Aera Therapeutics founded?

Aera Therapeutics was founded in 2021.

Where is Aera Therapeutics headquartered?

Aera Therapeutics is headquartered in Boston, United States.

What industry is Aera Therapeutics in?

Aera Therapeutics operates in Biotech, Drug Discovery, Therapeutics.

How many employees does Aera Therapeutics have?

Aera Therapeutics has 51-200 employees.

Aera Therapeutics

Unlocking the potential of genetic medicines.

Boston, United States · Founded 2021 · $193.0M raised

Biotech

Drug Discovery

Therapeutics

Headquarters: Boston
Employees: 51–200
Founded: 2021
Business Model: B2B

Website: aeratx.com
Total Funding: $193.0M
Last Round: $193.0M Series AFeb 2023
Rounds: 1

About

Aera Therapeutics is developing next-generation genetic medicines by solving the delivery challenge. Their proprietary platforms — targeted lipid nanoparticles (tLNPs), antibody oligonucleotide conjugates (AOCs), and protein nanoparticles (PNPs) — enable precise delivery of genetic therapies across tissues and disease areas to benefit more patients.

Summary

Aera Therapeutics is a Biotech company based in Boston, United States, founded in 2021. It has raised $193.0M in total across 1 round, most recently a $193.0M Series A round in Feb 2023. Investors include ARCH Venture Partners, GV and Lux Capital.

LinkedIn X (Twitter)